基本信息
浏览量:405
职业迁徙
个人简介
I am a basic scientist with a passion for exploiting the emerging information on dysregulated signaling circuitries and individual genomic and molecular alterations to develop new precision therapies to prevent and treat cancer.
My laboratory has focused on the study of growth-promoting signal transduction pathways, the nature of the dysregulated signaling networks in cancer, and on the use of genomic, proteomic, and system biology approaches to study cancer initiation and progression. Specifically, we have shown that human and virally-encoded G proteins and G protein coupled receptors (GPCRs) can display potent oncogenic activity. Emerging evidence from our laboratory has revealed that malignant cells often hijack the normal physiological functions of GPCRs to proliferate autonomously, evade immune detection, enhance their nutrient and oxygen supply, invade their surrounding tissues, and disseminate to other organs. Strikingly, our recent analysis of human cancer genomes revealed an unanticipated high frequency of mutations in G proteins and GPCRs in most tumor types. Indeed, nearly 30% of all human cancers harbor mutations in GPCRs or G proteins. We are now investigating the mechanisms by which genetic mutations in Gαq proteins initiate uveal and cutaneous melanoma, the role of Gαs and its target, PKA, in cancer, with emphasis on colorectal cancer, and how mutations and autocrine activation of GPCRs contribute to tumor progression, immune evasion, and therapy resistance.
In parallel, we are exploring the role of the mTOR pathway in head and neck cancer, a disease that results in 250,000 deaths each year worldwide. Based on our studies, and emerging results from our multi-institutional clinical trial targeting mTOR in oral cancer, we are now investigating the effectiveness and mechanism of action of PI3K/mTOR inhibitors for oral cancer prevention and treatment, as single agents and as part of novel signal transduction-based co-targeting strategies.
My laboratory has focused on the study of growth-promoting signal transduction pathways, the nature of the dysregulated signaling networks in cancer, and on the use of genomic, proteomic, and system biology approaches to study cancer initiation and progression. Specifically, we have shown that human and virally-encoded G proteins and G protein coupled receptors (GPCRs) can display potent oncogenic activity. Emerging evidence from our laboratory has revealed that malignant cells often hijack the normal physiological functions of GPCRs to proliferate autonomously, evade immune detection, enhance their nutrient and oxygen supply, invade their surrounding tissues, and disseminate to other organs. Strikingly, our recent analysis of human cancer genomes revealed an unanticipated high frequency of mutations in G proteins and GPCRs in most tumor types. Indeed, nearly 30% of all human cancers harbor mutations in GPCRs or G proteins. We are now investigating the mechanisms by which genetic mutations in Gαq proteins initiate uveal and cutaneous melanoma, the role of Gαs and its target, PKA, in cancer, with emphasis on colorectal cancer, and how mutations and autocrine activation of GPCRs contribute to tumor progression, immune evasion, and therapy resistance.
In parallel, we are exploring the role of the mTOR pathway in head and neck cancer, a disease that results in 250,000 deaths each year worldwide. Based on our studies, and emerging results from our multi-institutional clinical trial targeting mTOR in oral cancer, we are now investigating the effectiveness and mechanism of action of PI3K/mTOR inhibitors for oral cancer prevention and treatment, as single agents and as part of novel signal transduction-based co-targeting strategies.
研究兴趣
论文共 973 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Letters (2024): 217089
Jiyoung Yun,Robert Saddawi-Konefka,Benjamin Goldenson,Riyam Al-Msari,Davide Bernareggi, Jaya L. Thangaraj,Shiqi Tang, Sonam H. Patel, Sarah M. Luna,J. Silvio Gutkind,Dan Kaufman
JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 5 (2024)
Franziska Haderk,Yu-Ting Chou,Lauren Cech,Celia Fernandez-Mendez,Johnny Yu,Victor Olivas,Ismail M. Meraz,Dora Barbosa Rabago,D. Lucas Kerr,Carlos Gomez,David V. Allegakoen,Juan Guan,Khyati N. Shah,Kari A. Herrington,Oghenekevwe M. Gbenedio,Shigeki Nanjo,Mourad Majidi,Whitney Tamaki, Yashar K. Pourmoghadam,Julia K. Rotow,Caroline E. McCoach,Jonathan W. Riess,J. Silvio Gutkind,Tracy T. Tang,Leonard Post,Bo Huang,Pilar Santisteban,Hani Goodarzi,Sourav Bandyopadhyay,Calvin J. Kuo,Jeroen P. Roose, Wei Wu,Collin M. Blakely, Jack A. Roth,Trever G. Bivona
Cancer discoveryno. 7 (2024): 1143-1144
Keiichi Koshizuka,Xingyu Wu,Kuniaki Sato, Pham Thuy Vo, Gosia M. Murawska, Tomohiko Ishikawa,Zhiyong Wang,Alfredo A. Molinolo, Edward A. Dennis,Prashant Mali,J. Silvio Gutkind
Cancer Researchno. 6_Supplement (2024): 5996-5996
crossref(2024)
Chakit Arora,Marin Matic, Luisa Bisceglia,Pierluigi Di Chiaro,Natalia De Oliveira Rosa,Francesco Carli,Lauren Clubb, Lorenzo Amir Nemati Fard, Giorgos Kargas,Giuseppe R. Diaferia,Ranka Vukotic,Luana Licata,Guanming Wu,Gioacchino Natoli,J. Silvio Gutkind,Francesco Raimondi
Cell genomicsno. 5 (2024): 100557-100557
CANCER CELLno. 6 (2024): 930-933
Cancer Researchno. 6_Supplement (2024): 4745-4745
加载更多
作者统计
#Papers: 972
#Citation: 63844
H-Index: 131
G-Index: 229
Sociability: 8
Diversity: 0
Activity: 5
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn